Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Helms

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
JAMA Cardiology|July 2, 2025
Location of LMNA Variants and Clinical Outcomes in CardiomyopathyAshwin Bhaskaran, Rabah Ben Yaou, Adam S Helms, et al.
European Heart Journal|September 7, 2021
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathyVictor Nauffal, Peter Marstrand, Larry Han, et al.
Circulation|October 10, 2018
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)Carolyn Y Ho, Sharlene M Day, Euan A Ashley, et al.
JACC. Heart Failure|November 9, 2024
The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic CardiomyopathyMonica Ahluwalia, Jiankang Liu, Iacopo Olivotto, et al.
Circulation. Genomic and Precision Medicine|December 7, 2020
Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic CardiomyopathyNeal K Lakdawala, Iacopo Olivotto, Sharlene M Day, et al.
Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of <i>MYBPC3</i> Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
Circulation|May 25, 2023
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe RegistrySarah Abou Alaiwi, Thomas M Roston, Peter Marstrand, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic CardiomyopathyAlexandra Butters, Clare Arnott, Joanna Sweeting, et al.
Circulation|October 2, 2024
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE RegistryNiccolò Maurizi, Panagiotis Antiochos, Anjali Owens, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
JAMA Cardiology|July 2, 2025
Location of LMNA Variants and Clinical Outcomes in CardiomyopathyAshwin Bhaskaran, Rabah Ben Yaou, Adam S Helms, et al.
European Heart Journal|September 7, 2021
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathyVictor Nauffal, Peter Marstrand, Larry Han, et al.
Circulation|October 10, 2018
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)Carolyn Y Ho, Sharlene M Day, Euan A Ashley, et al.
JACC. Heart Failure|November 9, 2024
The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic CardiomyopathyMonica Ahluwalia, Jiankang Liu, Iacopo Olivotto, et al.
Circulation. Genomic and Precision Medicine|December 7, 2020
Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic CardiomyopathyNeal K Lakdawala, Iacopo Olivotto, Sharlene M Day, et al.
Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of <i>MYBPC3</i> Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
Circulation|May 25, 2023
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe RegistrySarah Abou Alaiwi, Thomas M Roston, Peter Marstrand, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic CardiomyopathyAlexandra Butters, Clare Arnott, Joanna Sweeting, et al.
Circulation|October 2, 2024
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE RegistryNiccolò Maurizi, Panagiotis Antiochos, Anjali Owens, et al.
Pageof 6